136056-99-0

Basic information

• Product Name: 2-Propanone, 1-(1,3-benzodioxol-5-yl)-, oxime, (E)-
• CAS NO: 136056-99-0
• Molecular Formula: C10H11NO3
• Molecular Weight: 193.202
• Mol File: 136056-99-0.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 2-Propanone, 1-(1,3-benzodioxol-5-yl)-, oxime, (E)-(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Propanone, 1-(1,3-benzodioxol-5-yl)-, oxime, (E)-(136056-99-0)
• EPA Substance Registry System: 2-Propanone, 1-(1,3-benzodioxol-5-yl)-, oxime, (E)-(136056-99-0)

Safety Data

• Hazardous Substances Data: 136056-99-0(Hazardous Substances Data)

Upstream product

• 4676-39-5 1-(1,3-benzodioxol-5-yl)-2-propanone 
• 5438-41-5 5-(2-nitroprop-1-enyl)benzo[d][1,3]dioxole 
• 120-58-1 isosafrole 
• 5438-41-5 2-nitro-1-(3,4-methylenedioxyphenyl)-1-propene 

Downstream Products

• 74698-47-8 N-hydroxy-3,4-methylenedioxyamphetamine 
• 123965-42-4 3-benzyloxy-benzoic acid-(2-benzo[1,3]dioxol-5-yl-1-methyl-ethylamide) 
• 4764-17-4 3,4-methylenedioxyamphetamine 

Relevant articles and documents

Indium-mediated reduction of β-nitrostyrenes to oximes in aqueous media

β-Nitrostyrenes are selectively reduced to the corresponding oximes in high yields by indium metal in aqueous methanol under neutral reaction conditions.

Highly Selective Reduction of Conjugated Nitroalkenes with Zinc Borohydride in DME

Zinc borohydride in 1,2-dimethoxyethane reduces α-substituted conjugated nitroalkenes to the corresponding oximes and non-α-substituted ones to the corresponding nitroalkanes in excellent yields.

Centrally active N-substituted analogs of 3,4-methylenedioxyphenylisopropylamine (3,4-methylenedioxyamphetamine)

The known central nervous system activity of 3,4-methylenedioxyphenylisopropylamine and its N-methyl homolog prompted the synthesis of a series of analogs with substituents on the nitrogen atom. Most of these analogs (R = alkyl, alkenyl, hydroxy, alkoxy, and alkoxyalkyl) were prepared by the reductive alkylation of 3,4-methylenedioxyphenylacetone with the appropriate amine and sodium cyanoborohydride. Hindered isomers were synthesized indirectly. Measurements of their pharmacological activity in several animal assays and in human subjects indicated that the central activity decreased with the increasing bulk of the N-substituent.